
BioVenture VoiCes with Chris Garabedian
BiotechTVAudio
- Format:
- Podcast
- New episodes:
- Every two weeks
- Typical length:
- about 1 hour 10 minutes
- Latest episode:
About this show
Hosted by Chris Garabedian, meet the leading Voices in the BioVenture community and hear their insights and perspectives on the challenges and successes with VC investing.
Covers: biotech, venture capital, life sciences investing, healthcare investing, biopharma industry, startup funding, medical devices, precision oncology
Show details and episodes come from the publisher's public feed at anchor.fm. Last updated . Names, artwork and text belong to their publishers.
Recently on this show
Summary of recent episodes, drawn from the publisher's feed.
This podcast features conversations with leading venture investors in biotech about the challenges and successes of backing companies. Recent episodes cover corporate venture investing with Sanofi Ventures' Jason Hafler and early biotech history with Third Rock Ventures' Bob Tepper.
Cosmos
Similar in subject
- Project Medtech
Both cover: medical devices, startup funding, venture capital - Cell & Gene: The Podcast
Both cover: biopharma industry, precision oncology - The Biotech Startups Podcast
Both cover: biotech, venture capital
Similar shows
Explore more
Episodes
Episode 12: Flagship Pioneering's Avak Kahvejian
· 1 hr 2 min
A General Partner at Flagship Pioneering, Avak describes his upbringing and studies in the Middle East and Montreal, Canada, working in industry at Helicos, and co-founding companies at Flagship since 2011. He discusses Flagship's unique platform of company building and innovation.
Not rated yetEpisode 11: Pillar VC's Tony Kulesa
· 1 hr 16 min
A Partner at Pillar VC, Tony describes his start at MIT, founding the MIT BioMakerspace, his work at Petri, being an early supporter of Nucleate, and his philosophy of not being overly influenced by what is in vogue today.
Not rated yetEpisode 10: Curie.Bio's Alexis Borisy
· 1 hr 20 min
The Co-Founder and Operating Chairman of Curie.Bio, and serial entrepreneur, shares experiences from his early life, CombinatoRx, Foundation Medicine, Third Rock, EQRx and more.
Not rated yetEpisode 9: Alloy Therapeutics & 82VS's Errik Anderson
· 1 hr 13 min
He describes his career path and learnings from the tech industry, co-founding Adimab, the work that Alloy and 82VS do to support and invest in scientist-entrepreneurs, and why he believes smaller organizations are best suited for discovery work and other early stage innovation.
Not rated yetEpisode 8: Canaan Partners' Julie Grant
· 1 hr 7 min
A general partner the firm, she describes her career path, including time spent at Goldman Sachs and Genentech, before landing at Canaan over a decade ago. She discusses the firm's investment approach to healthcare, and boldly moving into new categories of medicine even in cases where an organization doesn't have existing commercial infrastructure.
Not rated yetEpisode 7: MPM BioImpact's Ansbert Gadicke
· 1 hr 10 min
MPM's founder and managing partner discusses the firm's 30+ years of investing in life sciences, including the philosophy of placing entrepreneur partners at companies from the start, and teaming up with research institutions and investment collaborators. Plus, the keys making it through a down cycle like the industry has been in over recent years.
Not rated yetEpisode 6: Omega Funds' Otello Stampacchia
· 1 hr 15 min
He describes his career path, including time in the lab and doing quant work at Goldman Sachs. Plus, what he has learned about VC investing and biotech over time, and how Omega Funds is able to successfully invest in various stages and rounds of companies.
Not rated yetEpisode 5: KdT Ventures' Founder and Managing Partner Cain McClary
· 1 hr 4 min
He describes this path to venture investing from his start in science at the NIH to becoming a pathologist, and eventually raising a modest first fund and building off of its success. Plus, his investment philosophy and investing in science - including outside of therapeutics.
Not rated yetEpisode 4: Enavate Sciences’ Sara Nayeem
· 1 hr 3 min
Sara Nayeem describes her career path and how different firms she has worked for have had different approaches to investing. She introduces us to Enavate Sciences, and shares her thoughts on investing in various areas such as rare diseases and digital health.
Not rated yetEpisode 3: Time BioVentures' D.A. Wallach
· 1 hr 4 min
D.A. Wallach describes how he went from music to healthcare/biotech investing, and the similarities he sees between the two industries. Plus, the firm's investment philosophy and how he partnered with Tim Wright to create the firm.
Not rated yet